Suppr超能文献

作为潜在抗炎剂的羧酸取代塞来昔布电子等排体的设计、合成与评价

Design, synthesis, and evaluation of carboxylic acid-substituted celecoxib isosteres as potential anti-inflammatory agents.

作者信息

Song Zi-Jie, Wu Xiao-Fei, Zhou Zhi-Ya, Zhang Jing-Jing, Pan Yan-Yan, Dong Xue, Pang Xuan, Xie Ya-Ping, Sun Juan, Zhang Yu, Qin Jie

机构信息

School of Life Sciences and Medicine, Shandong University of Technology, Zibo, 255049, PR China.

Qilu Medical University, Zibo, 255300, PR China.

出版信息

Eur J Med Chem. 2025 Mar 15;286:117286. doi: 10.1016/j.ejmech.2025.117286. Epub 2025 Jan 17.

Abstract

A library comprising twenty-four isosteric derivatives of celecoxib substituted with carboxylic acid (labeled as 5a-5x), was synthesized and characterized through H NMR, C NMR, HRMS, and elemental analysis. Molecular docking studies revealed that all compounds successfully docked into the binding pocket of COX-2, and the introduction of carboxyl group enhances the interaction between the derivatives and COX-2. The compounds were further evaluated for cell toxicity, and in vitro anti-inflammatory activity. Notably, compound 5l exhibited significant inhibition of both COX-2 and NO release in vitro in comparison to the standard compound, displaying the highest selectivity towards the COX-2 enzyme (SI = 295.9) in comparison to celecoxib (SI = 261.3). 5l also exhibited the most potent anti-inflammatory activity and safety (ulcer index = 5.2) in vivo comparable to celecoxib at the same concentration. Through the molecular modeling and dynamics analysis, it was observed that compound 5l effectively stabilized within the active binding site of COX-2 through strong hydrogen bond interactions, and through the ADMET studies investigated the physiochemical properties and drug-likeliness behavior of compound 5l. In conclusion, compound 5l demonstrated to be a potential selective COX-2 anti-inflammatory candidate with reduced gastrointestinal risks.

摘要

合成了一个包含24种用羧酸取代的塞来昔布等排衍生物(标记为5a - 5x)的文库,并通过氢核磁共振、碳核磁共振、高分辨质谱和元素分析对其进行了表征。分子对接研究表明,所有化合物均成功对接至COX - 2的结合口袋,且羧基的引入增强了衍生物与COX - 2之间的相互作用。对这些化合物进一步进行了细胞毒性和体外抗炎活性评估。值得注意的是,与标准化合物相比,化合物5l在体外对COX - 2和一氧化氮释放均表现出显著抑制作用,与塞来昔布(SI = 261.3)相比,对COX - 2酶表现出最高的选择性(SI = 295.9)。在体内,5l在相同浓度下与塞来昔布相比,还表现出最有效的抗炎活性和安全性(溃疡指数 = 5.2)。通过分子建模和动力学分析观察到,化合物5l通过强氢键相互作用有效地稳定在COX - 2的活性结合位点内,并通过药物代谢动力学(ADMET)研究考察了化合物5l的理化性质和类药行为。总之,化合物5l被证明是一种潜在的选择性COX - 2抗炎候选药物,具有降低的胃肠道风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验